Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Lifevantage director Darwin Lewis buys shares worth $3,142

Published 03/18/2024, 07:17 PM
Updated 03/18/2024, 07:17 PM
© Reuters.

Lifevantage Corp (NASDAQ:LFVN) director Darwin Lewis has expanded his stake in the company through the purchase of additional shares, according to the latest SEC filings. The transactions, which took place on March 15, 2024, involved Lewis acquiring a total of 449 shares of Lifevantage common stock.

The shares were bought at prices ranging from $6.9356 to $6.9999, amounting to a total investment of $3,142. This purchase was conducted under an automatic purchase plan, as per Rule 10b5-1, which was established by Lewis on June 13, 2023. Such plans allow company insiders to set up predetermined trading arrangements for buying or selling stock at a future date, which can provide an affirmative defense against accusations of trading on inside information.

Following the recent acquisitions, Lewis now holds a total of 107,502 shares in the company. The purchase signifies a vote of confidence in the future of Lifevantage, a pharmaceutical preparations company based in Lehi, Utah.

Investors often monitor insider buying as it can be a signal of the management's belief in the company's prospects or that the stock may be undervalued. Lewis's recent stock purchases may therefore be of interest to current and potential shareholders alike.

Lifevantage Corp has not released any official statement regarding the transactions at this time.

InvestingPro Insights

Director Darwin Lewis's recent purchase of Lifevantage Corp (NASDAQ:LFVN) shares is a positive signal to the market, and a deeper look at the company's financials through InvestingPro can provide additional context. Lifevantage's management has demonstrated confidence in the company's financial health, as evidenced by aggressive share buybacks, an InvestingPro Tip that suggests a bullish outlook from those at the helm.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro data further reveals that Lifevantage holds a market capitalization of $89.05M with an adjusted price-to-earnings (P/E) ratio for the last twelve months as of Q2 2024 standing at 27.37. This is complemented by a notable gross profit margin of 79.65%, indicating the company's ability to maintain profitability on its products and services. Additionally, with a dividend yield of 2.02%, Lifevantage appears to offer a balance of growth and income potential.

Another InvestingPro Tip highlights the company's strong liquidity position, as its liquid assets exceed short-term obligations. This tip is particularly relevant to investors looking for companies with a solid financial footing. For those interested in further insights, there are 9 additional InvestingPro Tips available, offering a comprehensive analysis of Lifevantage's financial health and future outlook.

Investors seeking to make informed decisions may consider exploring these metrics and tips in greater detail. To access the full suite of insights, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.